Elucidata
About:
Elucidata delivers ML-ready biomedical molecular data that is curated to accelerate drug discovery.
Website: http://www.elucidata.io
Twitter/X: elucidatacorp
Top Investors: F-Prime Capital, Eight Roads Ventures, IvyCap Ventures, Hyperplane, TiE SoCal Angels
Description:
Elucidata's proprietary SaaS platform, Polly, transforms drug discovery- one curated dataset at a time. Polly delivers ML-ready biomedical molecular data for accelerated drug discovery. Hosting a rich repository of more than 230,000 multi-omic datasets, Polly curates data semi-automatically, with over 50,000 datasets added each month. The company equips data-driven drug discovery teams with a code-first SaaS platform that integrates proprietary and public biomedical molecular data for ML applications. Inspired by the FAIR guidelines described by the NIH, Polly's Data Lakes allow exclusive access to curated multi-omics data that is ready for ML workflows. Polly offers 10x faster identification of therapeutic assets with high odds of success in the clinic. It has enabled the detection of multiple validated drug targets across immunology, oncology, and metabolomic disorders. Polly supports discovery programs at Pfizer, Agios Pharmaceuticals, Genentech, and Yale and has 35+ research partners from premier biopharma companies and research labs.
$23.6M
$10M to $50M
Cambridge, Massachusetts, United States
2015-01-01
info(AT)elucidata.io
Abhishek Jha, Richard Kibbey, Swetabh Pathak
101-250
2022-09-27
Private
© 2024 MyAiNote.com